(PGNX) |
| 0 (0%) 04-19 07:11 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 13.15 |
| Resistance 1: | 11.26 |
| Pivot price: | 11.07 |
| Support 1: | 11.01 |
| Support 2: | 10.86 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 22 Nov 2022
Clinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation - BioSpace
Thu, 07 Nov 2019
Progenics (PGNX) Reports Q3 Loss, Lags Revenue Estimates - Yahoo! Canada
Thu, 25 Jul 2019
Progenics Pharmaceuticals Announces Collaboration with - GlobeNewswire
Wed, 17 Jul 2019
Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets - PR Newswire
Thu, 11 Oct 2018
Progenics Advances 1095, PSMA-Targeted Therapeutic - GlobeNewswire
Thu, 13 Sep 2018
Here's Why Shares of Progenics Pharmaceuticals Inc. Sank Today - The Motley Fool
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
